Pharvaris N.V. (PHVS)
NASDAQ: PHVS · Real-Time Price · USD
25.62
+0.62 (2.48%)
Jan 9, 2026, 9:38 AM EST - Market open
Pharvaris Market Cap
Pharvaris has a market cap or net worth of $1.66 billion as of January 9, 2026. Its market cap has increased by 56.81% in one year.
Market Cap
1.66B
Enterprise Value
1.24B
1-Year Change
56.81%
Ranking
Category
Stock Price
$25.62
Market Cap Chart
Since the IPO on February 5, 2021, Pharvaris's market cap has increased from $636.80M to $1.66B, an increase of 161.35%. That is a compound annual growth rate of 21.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 8, 2026 | 1.62B | -9.91% |
| Dec 31, 2025 | 1.80B | 73.39% |
| Dec 31, 2024 | 1.04B | -28.87% |
| Dec 29, 2023 | 1.46B | 284.53% |
| Dec 30, 2022 | 380.11M | -20.27% |
| Dec 31, 2021 | 476.72M | -25.14% |
| Feb 5, 2021 | 636.80M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 952.72B |
| Johnson & Johnson | 493.40B |
| AbbVie | 395.77B |
| UnitedHealth Group | 316.11B |
| AstraZeneca | 293.89B |
| Merck & Co. | 270.22B |
| Novartis AG | 268.87B |
| Novo Nordisk | 253.02B |